<DOC>
	<DOCNO>NCT01261234</DOCNO>
	<brief_summary>CAS-CARE study conduct evaluate inhibitory effect cilostazol , compare antiplatelet drug , in-stent restenosis follow carotid artery stenting ( CAS ) patient schedule undergo CAS . Study design Multicenter Prospective Ranodomized Controlled Study , rondomized cilostazol/non-cilostazol group prior CAS . 900 patient enrol 2 year follow 2 year in-stent restenosis CAS , evaluate carotid ultrasound angiography .</brief_summary>
	<brief_title>Carotid Artery Stenting With Cilostazol Addition Restenosis</brief_title>
	<detailed_description>Restenosis carotid artery stenting ( CAS ) critical issue . Cilostazol reduce restenosis intervention coronary femoropopliteal artery . The investigator confirm publish periprocedural cilostazol administration reduce incidence in-stent restenosis ( ISR ) target vessel revascularization ( TVR ) CAS , retrospectively . CAS-CARE study Multicenter Prospective Ranodomized Controlled Study . Patients , schedule CAS within 30 day , 50 % symptomatic carotid stenosis 80 % asymptomatic carotid stenosis , enroll randomize cilostazol/non-cilostazol group . 900 patient enrol 2 year follow 2 year in-stent restenosis CAS , evaluate carotid ultrasound angiography . And , evaluate cardiovascular event , include stroke , myocardial infarction , hemorrhagic event periprocedural period follow period . In study , ISR diagnose ultrasound DSA/CTA . Equivalence CTA ultrasound study .</detailed_description>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>50 % symptomatic carotid artery stenosis 80 % asymptomatic carotid artery stenosis schedule carotid artery stenting within 30 day 45 yearsold less 80 year old antiplatelet agent administratered orally followup anticipate possible 2 year CAS selfsupporoted daily activity ( modify Rankin Scale 2 less ) patient give informed consent participation study receive endovascular interevention schedule bilateral carotid intervention aortitis cvasculitis congessive heart failure ischemic stroke within 48 hour hemorrhagic stroke within 90 day renal failure</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Carotid Artery Disease</keyword>
	<keyword>Carotid Artery Stenting</keyword>
	<keyword>In stent restenosis</keyword>
	<keyword>Cardiovascular event</keyword>
	<keyword>Intima Media Thickness</keyword>
</DOC>